228 related articles for article (PubMed ID: 37699603)
21. Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies?
Benito V; Carballo S; Silva P; Esparza M; Arencibia O; Federico M; Andújar M; Mori M; Medina N; Lubrano A
J Minim Invasive Gynecol; 2017; 24(4):609-616. PubMed ID: 28161495
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
Hirata K; Kodaira T; Tomita N; Ohshima Y; Ito J; Tachibana H; Nakanishi T; Fuwa N
Jpn J Clin Oncol; 2014 Jun; 44(6):556-63. PubMed ID: 24755546
[TBL] [Abstract][Full Text] [Related]
23. Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer.
Mayadev JS; Enserro D; Lin YG; Da Silva DM; Lankes HA; Aghajanian C; Ghamande S; Moore KN; Kennedy VA; Fracasso PM; Schilder RJ
JAMA Oncol; 2020 Jan; 6(1):92-99. PubMed ID: 31774464
[TBL] [Abstract][Full Text] [Related]
24. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
Binbin T; Lingying W; Manni H; Jusheng A; Ning L
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of addition of conventional treatment to concurrent chemoradiotherapy in patients with FIGO stage III-IV cervical cancer: a retrospective analysis of a Japanese cohort.
Kurosu H; Todo Y; Yamada R; Minowa K; Tsuruta T; Minobe S; Nishiyama N; Kato H
Jpn J Clin Oncol; 2022 Mar; 52(3):244-250. PubMed ID: 34891157
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
[TBL] [Abstract][Full Text] [Related]
27. Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
Loverix L; Salihi RR; Van Nieuwenhuysen E; Concin N; Han S; van Gorp T; Vergote I
Int J Gynecol Cancer; 2020 Apr; 30(4):466-472. PubMed ID: 32079714
[TBL] [Abstract][Full Text] [Related]
28. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
[TBL] [Abstract][Full Text] [Related]
29. Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
Chen J; Li C; Cao Y; Zhu L; Zhang B; You J; Hou H; Wang J; Yuan Z
BMC Cancer; 2022 Jul; 22(1):793. PubMed ID: 35854236
[TBL] [Abstract][Full Text] [Related]
30. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.
Odunsi KO; Lele S; Ghamande S; Seago P; Driscoll DL
Eur J Gynaecol Oncol; 2001; 22(5):325-30. PubMed ID: 11766731
[TBL] [Abstract][Full Text] [Related]
31. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic retroperitoneal para-aortic lymph node biopsy in advanced cervical cancer with pelvic lymph node metastases: A single-center prospective study.
Yoshida K; Kondo E; Matsumoto T; Maki S; Kaneda M; Nii M; Hirata T; Ikeda T
J Obstet Gynaecol Res; 2021 Nov; 47(11):3951-3957. PubMed ID: 34409672
[TBL] [Abstract][Full Text] [Related]
33. Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.
Cho WK; Kim YJ; Kim H; Kim YS; Park W
Jpn J Clin Oncol; 2020 Sep; 50(10):1150-1156. PubMed ID: 32577748
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
[TBL] [Abstract][Full Text] [Related]
35. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
Cochrane Database Syst Rev; 2011 Apr; (4):CD008217. PubMed ID: 21491407
[TBL] [Abstract][Full Text] [Related]
36. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
[TBL] [Abstract][Full Text] [Related]
37. CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
Mayadev J; Nunes AT; Li M; Marcovitz M; Lanasa MC; Monk BJ
Int J Gynecol Cancer; 2020 Jul; 30(7):1065-1070. PubMed ID: 32447296
[TBL] [Abstract][Full Text] [Related]
38. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
39. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of multiple pelvic node metastases in cervical cancer patients treated with radical hysterectomy plus adjuvant chemoradiotherapy.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Ohta Y; Fujita M; Yoshino K; Enomoto T; Kamiura S; Kimura T
Int J Gynecol Cancer; 2012 Mar; 22(3):490-7. PubMed ID: 22367323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
